GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bonesupport Holding AB (FRA:2B4) » Definitions » EV-to-EBIT

Bonesupport Holding AB (FRA:2B4) EV-to-EBIT : 291.28 (As of May. 04, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Bonesupport Holding AB EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Bonesupport Holding AB's Enterprise Value is €1,274.94 Mil. Bonesupport Holding AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €4.38 Mil. Therefore, Bonesupport Holding AB's EV-to-EBIT for today is 291.28.

The historical rank and industry rank for Bonesupport Holding AB's EV-to-EBIT or its related term are showing as below:

FRA:2B4' s EV-to-EBIT Range Over the Past 10 Years
Min: -370.42   Med: -12.03   Max: 3930.43
Current: 296.66

During the past 10 years, the highest EV-to-EBIT of Bonesupport Holding AB was 3930.43. The lowest was -370.42. And the median was -12.03.

FRA:2B4's EV-to-EBIT is ranked worse than
97.39% of 460 companies
in the Medical Devices & Instruments industry
Industry Median: 20.215 vs FRA:2B4: 296.66

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Bonesupport Holding AB's Enterprise Value for the quarter that ended in Mar. 2024 was €1,269.78 Mil. Bonesupport Holding AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €4.38 Mil. Bonesupport Holding AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 0.34%.


Bonesupport Holding AB EV-to-EBIT Historical Data

The historical data trend for Bonesupport Holding AB's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bonesupport Holding AB EV-to-EBIT Chart

Bonesupport Holding AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.08 -46.72 -32.70 -78.59 641.08

Bonesupport Holding AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -113.08 -317.86 2,609.29 641.08 294.00

Competitive Comparison of Bonesupport Holding AB's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Bonesupport Holding AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bonesupport Holding AB's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bonesupport Holding AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Bonesupport Holding AB's EV-to-EBIT falls into.



Bonesupport Holding AB EV-to-EBIT Calculation

Bonesupport Holding AB's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1274.936/4.377
=291.28

Bonesupport Holding AB's current Enterprise Value is €1,274.94 Mil.
Bonesupport Holding AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.38 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bonesupport Holding AB  (FRA:2B4) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Bonesupport Holding AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=4.377/1269.77646
=0.34 %

Bonesupport Holding AB's Enterprise Value for the quarter that ended in Mar. 2024 was €1,269.78 Mil.
Bonesupport Holding AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.38 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bonesupport Holding AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Bonesupport Holding AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Bonesupport Holding AB (FRA:2B4) Business Description

Traded in Other Exchanges
Address
Scheelevagen 19, Lund, SWE, SE-223 70
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and sells injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and has the ability to release pharmaceuticals to promote healing. Its products focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: North America (NA) and Europe & Rest of the World (EUROW).

Bonesupport Holding AB (FRA:2B4) Headlines

No Headlines